Feline ocular tumors following ciliary body ablation with intravitreal gentamicin

Vet Ophthalmol. 2013 Jul:16 Suppl 1:188-90. doi: 10.1111/vop.12066. Epub 2013 May 22.

Abstract

Practitioners approach chemical ciliary body ablation (CBA) in cats with caution. In 1994, an academic letter proposed a potential link between intraocular gentamicin injections for glaucoma and the appearance of ocular tumors in cats (Veterinary and Comparative Ophthalmology, 4, 1994, 166). There is an historic perceived risk for the development of feline ocular post-traumatic sarcoma following gentamicin ciliary body ablation, and many clinicians refrain from chemical ablation in cats for this reason. A recent study discussed the possibility of a correlation between intravitreal gentamicin and tumor promotion in dogs (Veterinary Ophthalmology, 16, 2013, 159). We searched the Comparative Ocular Pathology Laboratory of Wisconsin (COPLOW) database for cases of cats diagnosed with ocular tumors following ciliary body ablation. Of eight cases with historic gentamicin injection, five had malignant tumors: three post-traumatic sarcomas and two melanomas.

Keywords: ciliary body ablation; feline; gentamicin; glaucoma; neoplasia; post-traumatic sarcoma.

MeSH terms

  • Animals
  • Cat Diseases / etiology
  • Cat Diseases / pathology*
  • Cats
  • Ciliary Body / pathology*
  • Eye Neoplasms / etiology
  • Eye Neoplasms / veterinary*
  • Female
  • Gentamicins / adverse effects*
  • Gentamicins / pharmacology*
  • Glaucoma / drug therapy
  • Glaucoma / veterinary
  • Intravitreal Injections / veterinary
  • Male
  • Pain / drug therapy
  • Pain / veterinary*
  • Retrospective Studies

Substances

  • Gentamicins